François P. Duhoux

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Rashmi K. Murthy, Sherene Loi, Alicia Okines et al. · New England Journal of Medicine · 2019 · 1.3K citations · Full text

Phase I Study of ⁶⁸Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma

Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk et al. · Journal of Nuclear Medicine · 2015 · 419 citations · Full text

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial

Fabrice André, Yeon Hee Park, Sung‐Bae Kim et al. · The Lancet · 2023 · 313 citations · Full text

Breast Oncology, Medicine, Clinical Trials +7

A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer

Wee Loon Ong, Maartje G. Schouwenburg, A.C.M. van Bommel et al. · JAMA Oncology · 2016 · 231 citations

Surgical Oncology, Cancer Management, Prognosis +16

Somatic Uniparental Isodisomy Explains Multifocality of Glomuvenous Malformations

Mustapha Amyere, Virginie Aerts, Pascal Brouillard et al. · The American Journal of Human Genetics · 2013 · 118 citations · Full text

Urology, Oculoplastics, Histopathology +4